Author’s Reply to Ma et al.: “Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis”
本文未提供摘要，请点击“查看全文”查看完整内容。